iifl-logo

Torrent Pharmaceuticals Ltd Quarterly Results

3,531.6
(-0.97%)
Sep 15, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Jun-2025Mar-2025Dec-2024Sept-2024Jun-2024

Gross Sales

3,128

2,909

2,762

2,831

2,815

Excise Duty

0

0

0

0

0

Net Sales

3,128

2,909

2,762

2,831

2,815

Other Operating Income

50

50

47

58

44

Other Income

-37

-18

33

-16

24

Total Income

3,141

2,941

2,842

2,873

2,883

Total Expenditure

2,146

2,019

1,895

1,950

1,955

PBIDT

995

922

947

923

928

Interest

56

56

57

64

75

PBDT

939

866

890

859

853

Depreciation

201

201

199

198

197

Minority Interest Before NP

0

0

0

0

0

Tax

201

184

153

156

126

Deferred Tax

-11

-17

35

52

73

Reported Profit After Tax

548

498

503

453

457

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

548

498

503

453

457

Extra-ordinary Items

0

-17.36

0

0

0

Adjusted Profit After Extra-ordinary item

548

515.36

503

453

457

EPS (Unit Curr.)

16.19

14.71

14.88

13.37

13.51

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

520

0

0

Equity

169.23

169.23

169.23

169.23

169.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

31.8

31.69

34.28

32.6

32.96

PBDTM(%)

30.01

29.76

32.22

30.34

30.3

PATM(%)

17.51

17.11

18.21

16

16.23

Torrent Pharma.: Related NEWS

Torrent Pharma to pick up 26% stake in subsidiary for new project

Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.

11 Sep 2025|01:43 PM
Read More
Torrent Pharma to Buy Additional 2.41% Stake in JB Chemicals for ₹620 Crore

The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.

4 Jul 2025|01:07 PM
Read More
Torrent Pharma to Acquire 49.19% Stake in JB Chemicals via ₹19,500 Crore Deal

The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.

30 Jun 2025|04:04 PM
Read More
Torrent Pharma logs 11% y-o-y growth in Q4 net profit

On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.

21 May 2025|11:02 AM
Read More
Top Stocks for Today - 27th January 2025

Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.

27 Jan 2025|07:44 AM
Read More
Torrent Pharma announces acquisition of 3 anti-diabetes brands

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

5 Dec 2024|09:04 AM
Read More
USFDA concludes Torrent Pharma’s inspection with VAI

The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.

22 Nov 2024|02:58 PM
Read More
Torrent Pharma promoter to pare 2.9% stake via block deal

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

30 Oct 2024|11:48 AM
Read More
Torrent Pharma Q2 Profit Soars 17.3%, Revenue Grows 8.6%

When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.

28 Oct 2024|12:16 PM
Read More
Torrent Pharma’s Shelcal 500 fails CDSCO quality test

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.

27 Sep 2024|02:40 PM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.